Clinical trials
Thyroid Neoplasms trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 9 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 19 |
| Recruiting | 8 |
| Completed | 6 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fujian Medical University | 8 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 4 |
| Bo Wang,MD | 3 |
| Fudan University | 2 |
| Ling Zhiqiang | 2 |
| Peking Union Medical College Hospital | 2 |
| Second Military Medical University | 2 |
| The First Affiliated Hospital of Xiamen University | 2 |
| Chongqing General Hospital | 1 |
| Ezisurg Medical Co. Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 38 |
| Thyroid Cancer, Papillary | 3 |
| Disease | 2 |
| Neoplasms | 2 |
| Recurrent Laryngeal Nerve Injuries | 2 |
| Thyroid Nodule | 2 |
| Accessory Nerve Injuries | 1 |
| Airway Obstruction | 1 |
| Carcinoma, Papillary | 1 |
| Head and Neck Neoplasms | 1 |
Trials
Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.